SLC22A1 and cholangiocarcinoma: The organic cation transporter 1 (OCT1) (SLC22A1), a functional transporter at the plasma membrane downregulated in CCA, contributes to sorafenib resistance in CCA (80, 97), leading to tumor progression and poor prognosis in human cholangiocarcinoma (98).